This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most common side effect of semaglutide, the weight loss and diabetes medication sold under the brand names Ozempic and ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the type 2 diabetes and weight loss medication sold under the brand names Ozempic and Wegovy — can expire. If you’ve ...

Studies show tirzepatide leads to significantly more weight loss on average compared to semaglutide. Tirzepatide and semaglutide are both FDA-approved weekly injections for weight management and type ...

In a phase III trial, orforglipron yielded better HbA1c reduction compared with oral semaglutide at 52 weeks. Gastrointestinal side effects were more common with orforglipron, leading to more ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program designed to help patients navigate the decision between semaglutide and tirzepatide, ...

This article was reviewed by Darragh O’Carroll, MD. Nausea is the most common side effect of semaglutide drugs like Ozempic® and Wegovy®. Luckily, there are plenty of steps you can take to feel better ...

Please provide your email address to receive an email when new articles are posted on . In patients with type 2 diabetes, CagriSema lowered HbA1c to a greater degree than semaglutide at 68 weeks.

Share on Pinterest Emerging evidence suggests that oral semaglutide may reduce the risk of heart failure–related events in people with type 2 diabetes. JasonDoiy/Getty Images Oral semaglutide may ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist. Topline data were ...